Results 101 to 110 of about 70,444 (292)

Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development

open access: yesNature Communications, 2017
Germline mutations of the SMARCB1 gene predispose to two distinct tumor syndromes: rhabdoid tumor predisposition syndrome, with malignant pediatric tumors mostly developing in brain and kidney, and familial schwannomatosis, with adulthood benign tumors ...
Jeremie Vitte   +4 more
semanticscholar   +1 more source

Rapidly Recurrent Exotropia After Surgery Unmasks an Oculomotor Nerve Meningioma: A Diagnostic Pitfall

open access: yes
The Kaohsiung Journal of Medical Sciences, EarlyView.
Ting‐En Chen   +3 more
wiley   +1 more source

Schwannoma of the Median Nerve: Diagnosis Sometimes Delayed

open access: yes, 2014
Schwannoma is a tumor that develops from nerve sheath. The authors report an unusual case of schwannoma of the median nerve (MN) that remained asymptomatic for four years.
Mohamed Azouz   +7 more
core   +1 more source

A Solitary Malignant Schwannoma in the Choana and Nasal Septum

open access: yesCase Reports in Otolaryngology, 2014
Malignant schwannoma is an extremely rare tumor and the risk of malignant schwannoma increases in patients with von Recklinghausen’s disease. Recently, we encountered a case of solitary malignant schwannoma in the choana and posterior nasal septum ...
Eun Jung Lee   +3 more
doaj   +1 more source

BRACHIAL PLEXUS SCHWANNOMA – CASE REPORT AND LITERATURE REVIEW

open access: yesActa Clinica Croatica, 2018
SUMMARY – Schwannoma as an extracranial nerve sheath tumor rarely affects brachial plexus. Due to the fact that brachial plexus schwannomas are a rare entity and due to the brachial plexus anatomic complexity, schwannomas in this region present a ...
Luka Vučemilo   +5 more
semanticscholar   +1 more source

Molecular heterogeneity and prognostic biomarkers in primary meningeal melanocytic tumors

open access: yesBrain Pathology, EarlyView.
Integrated molecular profiling reveals biological heterogeneity among primary meningeal melanocytic tumors, identifying intermediate‐grade PMMT subgroups with distinct recurrence risk. Molecular alterations including SF3B1 mutations and chromosome 8q gains support prognostic stratification, while PRKAR1A alterations and chromosome 17/21q losses aid ...
Rosina Paterra   +6 more
wiley   +1 more source

Gliomas with pleomorphic and pseudopapillary features (GPAP) are circumscribed tumors with targetable mutations, prolonged survival, and frequent tumor predisposition

open access: yesBrain Pathology, EarlyView.
DNA methylation profiling identifies GPAP as a distinct circumscribed glioma with a characteristic expansive, multicystic radiological appearance, pleomorphic and pseudopapillary histology, a recognizable CNV profile, druggable molecular alterations, and recurrent cancer predisposition syndromes.
Alberto Picca   +35 more
wiley   +1 more source

Penile Schwannoma

open access: yes, 2007
Bu makalede penis şaftına localize olmuş penil schwannoma lezyonu bulunan 35 yaşında bir vaka sunulmaktadır, tedavisinde cerrahi eksizyon yapılmış ve tanısı S-100 immünperoksidaz boyasıyla ...
Tansu Güdelci   +2 more
core  

Angiosarcoma arising in a vagal schwannoma - Report and literature review [PDF]

open access: yes
Schwannoma and angiosarcoma are rare occurrences. Angiosarcoma\u27s occurrence in a preexisting schwannoma is a very rare event with only fifteen cases reported in the literature. We report the sixteenth case of angiosarcoma arising in a schwannoma, a 30-
Naseem, Paras   +9 more
core   +1 more source

Schwannoma of the hypoglossal nerve: Review of the literature based on an illustrative case.

open access: yesMolecular and clinical oncology, 2017
Schwannomas are benign tumours that originate from the myelin sheath of peripheral nerves. They are characterised by a slow growth tendency. Benign schwannomas represent 35% of the head and neck district tumours. Hypoglossal schwannomas account for 5% of
R. Fornaro   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy